摘要：The United States Patent and Trademark Office and the federal courts are struggling to interpret biotechnol0gy patent claims. Deciding the scope of patent protection for biotechnology inventions I is a difficult task and has led to conflicting precedent, as illustrated by Scripps Clinic & Research Foundation v. Genentech, Inc. ("Scripps"), ~" Hormone Research Foundation v. Genentech, Inc. ("Hormone Research"), 3 and Genentech, btc. v. Wellcome Foututation ("Genentech').
